Regulation of inflammation in cancer by dietary eicosanoids

Pharmacol Ther. 2023 Aug:248:108455. doi: 10.1016/j.pharmthera.2023.108455. Epub 2023 May 29.

Abstract

Background: Cancer is a major burden of disease worldwide and increasing evidence shows that inflammation contributes to cancer development and progression. Eicosanoids are derived from dietary polyunsaturated fatty acids, such as arachidonic acid (AA), and are mainly produced by a series of enzymatic pathways that include cyclooxygenase (COX), lipoxygenase (LOX), and cytochrome P-450 epoxygenase (CYP). Eicosanoids consist of at least several hundred individual molecules and play important roles in the inflammatory response and inflammation-related cancers.

Scope and approach: Dietary sources of AA and biosynthesis of eicosanoids from AA through different metabolic pathways are summarized. The bioactivities of eicosanoids and their potential molecular mechanisms on inflammation and cancer are revealed. Additionally, current challenges and limitations in eicosanoid research on inflammation-related cancer are discussed.

Key findings and conclusions: Dietary AA generates a large variety of eicosanoids, including prostaglandins, thromboxane A2, leukotrienes, cysteinyl leukotrienes, lipoxins, hydroxyeicosatetraenoic acids (HETEs), and epoxyeicosatrienoic acids (EETs). Eicosanoids exert different bioactivities and mechanisms involved in the inflammation and related cancer developments. A deeper understanding of eicosanoid biology may be advantageous in cancer treatment and help to define cellular targets for further therapeutic development.

Keywords: Arachidonic acid; Cancer; Eicosanoids; Inflammation; Mechanisms.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arachidonic Acid / metabolism
  • Cyclooxygenase 2
  • Eicosanoids* / metabolism
  • Humans
  • Inflammation / metabolism
  • Leukotrienes
  • Neoplasms* / metabolism

Substances

  • Eicosanoids
  • Arachidonic Acid
  • Leukotrienes
  • Cyclooxygenase 2